MariPharm became the first company to receive a government license to grow, research, process and sell Medicinal Grade Cannabis.
MariPharm® has consistently utilized innovative technologies, and has developed a revolutionary extraction process for CBD that consistently guarantees the highest quality pharmaceutical-grade product, formulated from pure CBD extract produced according to the most stringent EU GMP standards.
Years of research supported by leading scientists, universities, government agencies, research institutes, pharmacists and doctors, backed by an Opium License from the Dutch Ministry of Health, Sports and Welfare, have resulted in high-quality and safe (CBD-) products.
MariPharm® maintains a dedicated, high-tech laboratory for quality control, with third-party quality oversight and testing guaranteed by renowned Dutch Government approved laboratory that issues Certificates of Analysis for each batch of CBD oil.
Maripharm is a ground-breaking Phyto-Pharmaceutical Company that produces the highest quality, pharmaceutical grade CBD oil in the world.
MariPharm was founded in the Netherlands in 1995 and for more than two decades has undertaken pioneering research into the cannabis plant.
MariPharm was the first company worldwide to receive a government license to grow, research, process and sell Medicinal Grade Cannabis (MGC) which they exclusively provided to the public between 1995 and 2003.
With over 30,000 patients having benefited from the use of MariPharm’s MGC products, they have a wealth of knowledge in the use of cannabis, especially when relating to strains and genetics of the plant for different impacts and ailments.
MariPharm products set the standard worldwide in producing and analysing cannabidiol with every batch going through stringent quality control measures to ensure the best quality product every time.
MariPharm has an extensive range of (patented) genetics at its disposal. The genetics are of a high and stable quality, achieved by 25 years of research and development.
MariPharm has several (interational) high-tech production locations. The production is standardized, without artificial additives, and is carefully monitored.
As soon as the CBD hemp has reached the optimal condition, the flowers are harvested. These subsequently undergo a special drying process.
MariPharm has been researching the optimal extraction technique since 1995. These years of experience ensure a clean and pure extract.
Each batch is analysed separately in both our own laboratory and in that of a third party certified by the government. If the quality meets Mari harm's standards, the batch is released by the quality manager.
MariPharm stands for quality, safety and effectiveness. MariPharm's BD products are sold exclusively by selected distributors and through the pharmacy.
Dedicated high-tech laboratory – with third-party quality oversight and testing of each batch of product guaranteed by a renowned laboratory approved by the Dutch government to issue Certificates of Analysis.
MariPharm maintains a state of the art manufacturing and grow facility.
“I have been interested in the developments in the CBD sector for some time now and have seen for myself the effectiveness. However, not all CBD products are the same, so after trial and error, I now only use MariPharm in the clinic – I trust the brand implicitly.”
MariPharm became the first company to receive a government license to grow, research, process and sell Medicinal Grade Cannabis.
The Royal Pharmaceutical Society of Great Britain invite MariPharm to the UK to discuss the therapeutic benefits of cannabinoids.
MariPharm break The Single Convention of New-York (1961) by exporting 1 Kilogram of MGC to the UK, licensed by the Dutch Ministry of Health Welfare and Sport.
MariPharm founder was granted a special benefit working license on medicinal cannabis from the Canadian authorities in order to consult for a large Canadian Medicinal Cannabis company.
MariPharm’s experienced team consulted on Medicinal Cannabis businesses around the globe. Countries include Israel, Czech Republic, Uruguay, U.S. and Canada.
The founder and CEO of Maripharm "Marcel de Wit" past away on the 6Th of July. The company is still developing new strains and genetics for medical purposes.
MariPharm also holds Dutch Government permits and currently has several new ground-breaking CBD products under development that will be introduced in the very near future.